IL17A and rheumatoid arthritis: Our results show that the down-regulated DEGs in the anti-TNF therapy-resistant CD patients vs. CD patients responding to the anti-TNF drug were clustered with the highest scoring in immune-related pathways, such as ‘IL-17 signaling’, ‘Cytokine-cytokine receptor interaction’, and ‘Rheumatoid arthritis’.